Five insights:
1. Medicrea now has 13 U.S.-issued patents for its UNiD technology. It plans to pursue additional patents.
2. The newly issued U.S. patents “create strong barriers to entry for competitors” and strengthen Medicrea’s market position, CEO and founder Denys Sournac said in a press release.
3. The company’s UNiD ASI offerings are designed to transform spinal surgery through artificial intelligence, predictive modeling and customized implants.
4. Medicrea says its platform can improve clinical and surgical workflow, increase reproducibility, boost surgical outcomes and help surgeons plan cases preoperatively.
5. More than 5,000 cases have been performed using the UNiD ASI technology platform, all with patient-specific implants.
More articles on spine and orthopedic devices:
SeaSpine launches midline posterior fixation system — 3 insights
AAOS awards highest honor to Dr. Dana Covey
Woman arrested for prescription fraud — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.